immunity News and Research

RSS

CD4 T-cell immunity active six months into COVID-19 convalescence

A new paper explores the presence of CD4 T-cell-mediated adaptive immunity against SARS-CoV-2 in late convalescence.

6 Mar 2022

Disruption of sleep and circadian rhythm can increase the chances of contracting a virus

A recent study explores the effect of sleep and circadian rhythm dispersion on mouse lung transcriptome after six of hours sleep deprivation.

6 Mar 2022

Third dose of COVID mRNA vaccine safe and effective in kidney transplant patients

An new study reports that a third dose of the Pfizer BNT162b2 vaccine produces high levels of anti-spike IgG antibodies in kidney transplant recipients.

6 Mar 2022

T-cell cytokine and fatty acid work together to trigger a type of cell death

Researchers at the University of Michigan Rogel Cancer Center found that a cytokine, a category of protein that acts as messengers in the body, and a fatty acid can work together to trigger a type of cell death previously defined by studies with synthetic molecules.

4 Mar 2022

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Scientists have recently revealed that memory T cell responses to common cold coronaviruses stably persist for a long time.

4 Mar 2022

Potential molecular and clinical biomarkers of COVID-19 severity

Researchers have reviewed the currently published data examining the potential molecular and clinical biomarkers of COVID-19 severity.

4 Mar 2022

Over a third vaccinated-but-unboosted adults have reservations about vaccinating children

While the vast majority of U.S. adults who are fully vaccinated and boosted against Covid-19 would be likely to recommend vaccinating a 5- to 11-year-old, over a third of fully vaccinated adults who have not had a booster shot have reservations about Covid-19 vaccination for a child that age, according to survey data analysis by the Annenberg Public Policy Center of the University of Pennsylvania.

3 Mar 2022

Effectiveness of mRNA vaccines, antibody treatment reduced by all three omicron subvariants

Only one currently authorized antibody treatment retains its activity against all Omicron subvariants, according to new research by scientists at Columbia University and the University of Hong Kong.

3 Mar 2022

Study shows the impact of COVID-19 restrictions on dengue cases in 2020

Nearly three quarters of a million fewer global cases of dengue occurred in 2020, which could be linked to COVID-19 disruptions limiting human mobility and contact, according to a new study published in Lancet Infectious Diseases.

3 Mar 2022

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

Researchers assess the efficacy of 8G3, a B-cell neutralizing antibody against SARS-CoV-2 variants, including the most recent Omicron variant.

3 Mar 2022

$The benefits of using fractional doses of COVID-19 vaccines$

The benefits of using fractional doses of COVID-19 vaccines

A new study published in PNAS assessed the benefits of using fractional doses for curbing the current COVID-19 pandemic.

3 Mar 2022

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Researchers found that infection with one Omicron sub-lineage of SARS-CoV-2 induces strong protection against reinfection with the other Omicron sub-lineage.

3 Mar 2022

Durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection

An new study published presents evidence that a prior history of infection with SARS-CoV-2 provides immunity that prevents reinfection for at least a year.

2 Mar 2022

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

A new study identifies the antigenic differences that exist between the Omicron BA.2 and BA.1 variants.

2 Mar 2022

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

The current study discusses a reliable ELISA that can detect three isotypes of antibody against three SARS-CoV-2 antigens.

2 Mar 2022

Population-level health and economic impact of the Pfizer-BioNTech COVID-19 vaccine in first year of rollout in the US

A new study shows the impact of the vaccine program on the state of public health in the USA.

2 Mar 2022

Study finds booster shot did produce effective levels of neutralizing antibodies against omicron

A new study using serum from human blood samples suggests neutralizing antibody levels produced by two-dose mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against the omicron variant.

2 Mar 2022

immunity News and Research

CD4 T-cell immunity active six months into COVID-19 convalescence

Disruption of sleep and circadian rhythm can increase the chances of contracting a virus

Third dose of COVID mRNA vaccine safe and effective in kidney transplant patients

T-cell cytokine and fatty acid work together to trigger a type of cell death

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Potential molecular and clinical biomarkers of COVID-19 severity

Over a third vaccinated-but-unboosted adults have reservations about vaccinating children

Effectiveness of mRNA vaccines, antibody treatment reduced by all three omicron subvariants

Study shows the impact of COVID-19 restrictions on dengue cases in 2020

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

The benefits of using fractional doses of COVID-19 vaccines

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

Population-level health and economic impact of the Pfizer-BioNTech COVID-19 vaccine in first year of rollout in the US

Study finds booster shot did produce effective levels of neutralizing antibodies against omicron

Government to revoke regulations making COVID-19 vaccination as a condition of deployment

mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News